{"id":11661,"date":"2018-05-11T00:00:00","date_gmt":"2018-05-10T22:00:00","guid":{"rendered":"http:\/\/web-server-devel.mgc.es\/assaigs-clinics-una-oportunitat-per-als-pacients\/"},"modified":"2021-03-11T10:12:13","modified_gmt":"2021-03-11T09:12:13","slug":"assaigs-clinics-una-oportunitat-per-als-pacients","status":"publish","type":"post","link":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/","title":{"rendered":"Assaigs cl\u00ednics: una oportunitat per als pacients"},"content":{"rendered":"<div class=\"video\"><iframe loading=\"lazy\" src=\"https:\/\/player.vimeo.com\/video\/269829317\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"\"><\/iframe><\/div>\n<p>Els assajos cl\u00ednics proven l&#8217;efic\u00e0cia i la seguretat de nous medicaments o t\u00e8cniques m\u00e8diques mitjan\u00e7ant la seva aplicaci\u00f3 en \u00e9ssers humans. El.<strong> Dr. Antoni Mayol, especialista en medicina general del <a href=\"http:\/\/www.mgc.es\/es\/centros-medicos\/centro-medico-mutua-general-de-cataluna\">Centre M\u00e8dic M\u00fatua General de Catalunya<\/a><\/strong>, ens parla sobre la rellev\u00e0ncia dels assajos cl\u00ednics en la pr\u00e0ctica m\u00e8dica quotidiana.<!--more--><\/p>\n<p><strong>Qu\u00e8 s\u00f3n els assaigs cl\u00ednics i com es realitzen?<\/strong> Els assaigs cl\u00ednics s\u00f3n una avaluaci\u00f3 experimental d&#8217;un procediment, una t\u00e8cnica quir\u00fargica, un producte sanitari o un f\u00e0rmac, per intentar con\u00e8ixer-ne la seguretat i\/o l\u2019efic\u00e0cia. Es tracta de comparar un f\u00e0rmac nou, que pensem que ser\u00e0 \u00fatil, amb f\u00e0rmacs o tractaments ja existents complint la normativa vigent a cada pa\u00eds o de cada regi\u00f3.<\/p>\n<p>Un cop les autoritats sanit\u00e0ries han aprovat aquest protocol (ja sigui a la comunitat aut\u00f2noma, a tot el pa\u00eds, a l\u2019\u00e0mbit europeu, etc.), es posa en marxa l&#8217;assaig cl\u00ednic en un nombre X de pacients, que es van controlant d&#8217;una manera peri\u00f2dica durant tota la realitzaci\u00f3. En funci\u00f3 de l\u2019objectiu poden ser m\u00e9s o menys llargs i es controla que no hi hagi reaccions adverses o que almenys siguin menors que les ja existents en altres tractaments. Un cop recollides les dades que s&#8217;han captat durant tota la durada de l&#8217;assaig cl\u00ednic, es realitza una an\u00e0lisi estad\u00edstica per veure de manera real si el f\u00e0rmac (o el que h\u00e0gim testat) \u00e9s superior o no a un altre ja existent.<\/p>\n<p>\u00c9s molt important per a aquesta pr\u00e0ctica que el pacient sigui informat d&#8217;una manera clara i que signi el que anomenem un &#8220;consentiment informat&#8221;. Sense aquesta signatura del pacient conforme coneix pros i contres, no es pot realitzar.<\/p>\n<p><strong>Quins objectius tenen els assaigs cl\u00ednics?<\/strong> L&#8217;objectiu pel que fa als metges, al personal sanitari que posa en marxa l&#8217;estudi i als pacients \u00e9s, b\u00e0sicament, veure si el nou f\u00e0rmac, procediment o t\u00e8cnica \u00e9s superior a un altre. I tots els beneficis estan enfocats al pacient, perqu\u00e8 si es comprova que l&#8217;assaig cl\u00ednic funciona, el personal sanitari disposar\u00e0 d\u2019una nova eina per poder aplicar-los un tractament millor.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4719\" src=\"https:\/\/www.mgc.es\/wp-content\/uploads\/2018\/05\/ensayo-clinico-redu.jpg\" alt=\"\" width=\"2000\" height=\"1334\"><\/p>\n<p><strong>Quin impacte tenen els assaigs cl\u00ednics i com s&#8217;avaluen?<\/strong> A casa nostra, l&#8217;impacte dels assajos cl\u00ednics \u00e9s molt gran perqu\u00e8 tenim un gran nombre de centres sanitaris i una gran poblaci\u00f3 en la qual hi ha un gran nombre de malalties. Per tant disposem d&#8217;un gran nombre de pacients amb patologies similars que podem estudiar a la vegada, si \u00e9s el cas.<\/p>\n<p><strong>Actualment, quin nivell d&#8217;aplicaci\u00f3 tenen els assaigs cl\u00ednics en la pr\u00e0ctica m\u00e8dica?<\/strong> A la pr\u00e0ctica m\u00e8dica, els assajos cl\u00ednic s\u00f3n molt importants. Avui dia, molts pacients amb una patologia i amb uns par\u00e0metres que puguin ser inclosos en l&#8217;assaig cl\u00ednic, es poden beneficiar dels diferents estudis que es fan en diferents hospitals. \u00c9s molt diferent del que passava fa uns anys, quan els assaigs cl\u00ednics estaven implementats exclusivament en certs pa\u00efsos i certs centres, amb la qual cosa els pacients, quan podien, havien de traslladar-se all\u00ed. Ara, al nostre pa\u00eds hi ha una gran quantitat d&#8217;assajos cl\u00ednics, de manera que es poden estudiar una gran varietat de patologies.<\/p>\n<p><strong>Com es podria augmentar la iniciativa i l&#8217;impacte dels assaigs cl\u00ednics?<\/strong> La posada en marxa d&#8217;assaigs cl\u00ednics b\u00e0sicament dep\u00e8n d&#8217;un tema econ\u00f2mic. La persona, grup de persones o ind\u00fastria farmac\u00e8utica a la qual interessa posar en marxa un assaig cl\u00ednic principalment ha de tenir en compte el tema econ\u00f2mic. La despesa de la posada en marxa i del seguiment de l\u2019evoluci\u00f3 \u00e9s molt alt i, per ara i malauradament, al nostre pa\u00eds la quantitat de qu\u00e8 disposa l&#8217;erari p\u00fablic per posar en marxa assaigs cl\u00ednics \u00e9s petita.<\/p>\n<p>B\u00e0sicament i com passa en molts pa\u00efsos, la principal promotora d&#8217;assajos cl\u00ednics \u00e9s la ind\u00fastria farmac\u00e8utica. Tant de bo, amb el temps, la quantitat d&#8217;inversi\u00f3 p\u00fablica que es pugui realitzar en aquest tipus de pacients i en aquest tipus d&#8217;experimentaci\u00f3, sigui molt m\u00e9s alta.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Els assajos cl\u00ednics proven l&#8217;efic\u00e0cia i la seguretat de nous medicaments o t\u00e8cniques m\u00e8diques mitjan\u00e7ant la seva aplicaci\u00f3 en \u00e9ssers humans.<\/p>\n","protected":false},"author":3,"featured_media":14401,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[402,413,481],"class_list":["post-11661","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salut","tag-centre-medic","tag-destacat","tag-prevencio"],"featured_image_src":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/2018_05_destacat_im_es.jpg","author_info":{"display_name":"Revista Inter\u00e8s Mutu","author_link":"https:\/\/www.mgc.es\/ca\/blog\/author\/interesmutu\/"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Assaigs cl\u00ednics: una oportunitat per als pacients - MGC M\u00fatua<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Assaigs cl\u00ednics: una oportunitat per als pacients - MGC M\u00fatua\" \/>\n<meta property=\"og:description\" content=\"Els assajos cl\u00ednics proven l&#039;efic\u00e0cia i la seguretat de nous medicaments o t\u00e8cniques m\u00e8diques mitjan\u00e7ant la seva aplicaci\u00f3 en \u00e9ssers humans.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/\" \/>\n<meta property=\"og:site_name\" content=\"MGC M\u00fatua\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/mgcmutua\" \/>\n<meta property=\"article:published_time\" content=\"2018-05-10T22:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-11T09:12:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/2018_05_destacat_im_es.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"288\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Revista Inter\u00e8s Mutu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mgcmutua\" \/>\n<meta name=\"twitter:site\" content=\"@mgcmutua\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Revista Inter\u00e8s Mutu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Assaigs cl\u00ednics: una oportunitat per als pacients - MGC M\u00fatua","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/","og_locale":"ca_ES","og_type":"article","og_title":"Assaigs cl\u00ednics: una oportunitat per als pacients - MGC M\u00fatua","og_description":"Els assajos cl\u00ednics proven l'efic\u00e0cia i la seguretat de nous medicaments o t\u00e8cniques m\u00e8diques mitjan\u00e7ant la seva aplicaci\u00f3 en \u00e9ssers humans.","og_url":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/","og_site_name":"MGC M\u00fatua","article_publisher":"https:\/\/www.facebook.com\/mgcmutua","article_published_time":"2018-05-10T22:00:00+00:00","article_modified_time":"2021-03-11T09:12:13+00:00","og_image":[{"width":1000,"height":288,"url":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/2018_05_destacat_im_es.jpg","type":"image\/jpeg"}],"author":"Revista Inter\u00e8s Mutu","twitter_card":"summary_large_image","twitter_creator":"@mgcmutua","twitter_site":"@mgcmutua","twitter_misc":{"Escrit per":"Revista Inter\u00e8s Mutu","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/#article","isPartOf":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/"},"author":{"name":"Revista Inter\u00e8s Mutu","@id":"https:\/\/www.mgc.es\/#\/schema\/person\/010c961d9c9acf38f11187a02b646c16"},"headline":"Assaigs cl\u00ednics: una oportunitat per als pacients","datePublished":"2018-05-10T22:00:00+00:00","dateModified":"2021-03-11T09:12:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/"},"wordCount":725,"commentCount":0,"publisher":{"@id":"https:\/\/www.mgc.es\/#organization"},"image":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/2018_05_destacat_im_es.jpg","keywords":["centre m\u00e8dic","destacat","prevenci\u00f3"],"articleSection":["Salut i medicina"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/#respond"]}]},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/","url":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/","name":"Assaigs cl\u00ednics: una oportunitat per als pacients - MGC M\u00fatua","isPartOf":{"@id":"https:\/\/www.mgc.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/#primaryimage"},"image":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/2018_05_destacat_im_es.jpg","datePublished":"2018-05-10T22:00:00+00:00","dateModified":"2021-03-11T09:12:13+00:00","breadcrumb":{"@id":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/#primaryimage","url":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/2018_05_destacat_im_es.jpg","contentUrl":"https:\/\/www.mgc.es\/wp-content\/uploads\/2019\/11\/2018_05_destacat_im_es.jpg","width":1000,"height":288},{"@type":"BreadcrumbList","@id":"https:\/\/www.mgc.es\/ca\/blog\/assaigs-clinics-una-oportunitat-per-als-pacients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mgc.es\/ca\/"},{"@type":"ListItem","position":2,"name":"Assaigs cl\u00ednics: una oportunitat per als pacients"}]},{"@type":"WebSite","@id":"https:\/\/www.mgc.es\/#website","url":"https:\/\/www.mgc.es\/","name":"MGC M\u00fatua","description":"MGC M\u00fatua \u00e9s una entitat asseguradora sense \u00e0nim de lucre constitu\u00efda al 1982 i especialitzada en assegurances de salut i assist\u00e8ncia.","publisher":{"@id":"https:\/\/www.mgc.es\/#organization"},"alternateName":"MGC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mgc.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.mgc.es\/#organization","name":"MGC Mutua","alternateName":"MGC","url":"https:\/\/www.mgc.es\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.mgc.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.mgc.es\/wp-content\/uploads\/2020\/03\/mgcmutua_h2_2t_reduccions.png","contentUrl":"https:\/\/www.mgc.es\/wp-content\/uploads\/2020\/03\/mgcmutua_h2_2t_reduccions.png","width":303,"height":165,"caption":"MGC Mutua"},"image":{"@id":"https:\/\/www.mgc.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/mgcmutua","https:\/\/x.com\/mgcmutua","https:\/\/www.youtube.com\/c\/MGCMutua"]},{"@type":"Person","@id":"https:\/\/www.mgc.es\/#\/schema\/person\/010c961d9c9acf38f11187a02b646c16","name":"Revista Inter\u00e8s Mutu","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/secure.gravatar.com\/avatar\/52302d684339b9d7bf5691e2ad00835d62ce3b4a435f21ca9f21fbe39c63cb1b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/52302d684339b9d7bf5691e2ad00835d62ce3b4a435f21ca9f21fbe39c63cb1b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/52302d684339b9d7bf5691e2ad00835d62ce3b4a435f21ca9f21fbe39c63cb1b?s=96&d=mm&r=g","caption":"Revista Inter\u00e8s Mutu"}}]}},"_links":{"self":[{"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/posts\/11661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/comments?post=11661"}],"version-history":[{"count":2,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/posts\/11661\/revisions"}],"predecessor-version":[{"id":21178,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/posts\/11661\/revisions\/21178"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/media\/14401"}],"wp:attachment":[{"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/media?parent=11661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/categories?post=11661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mgc.es\/ca\/wp-json\/wp\/v2\/tags?post=11661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}